Back to search
Infection by Streptococcus Group B
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infection by Streptococcus Group B trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Infection by Streptococcus Group B trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
To assess the safety and tolerability of IVT GBS-06 vaccine administered as a single-dose regimen, at three dosage levels in healthy, non-pregnant, adult women…
The main objective of this study : Demonstrate that GBS (group B streptococci) "ST-17" colonize and persist to 60 days twice in the digestive tract of newborns…
This is an open-label randomized control trial and feasibility study designed to determine the feasibility of a larger RCT in our setting that would examine pre…
Part A: The primary objective is to evaluate the safety and tolerability of a potential vaccine against Group B streptococcus. Part B: To evaluate the long ter…
The study investigated the immune response induced by the Group B streptococcus vaccine in healthy pregnant women. In addition, the study investigated the amoun…